Follow
Antonella D'Arminio Monforte
Antonella D'Arminio Monforte
Unknown affiliation
Verified email at unimi.it
Title
Cited by
Cited by
Year
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
21012003
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
M Egger, M May, G Chêne, AN Phillips, B Ledergerber, F Dabis, ...
The Lancet 360 (9327), 119-129, 2002
21002002
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
Antiretroviral Therapy Cohort Collaboration
The Lancet 372 (9635), 293-299, 2008
20002008
Changing patterns of mortality across Europe in patients infected with HIV-1
A Mocroft, S Vella, TL Benfield, A Chiesi, V Miller, P Gargalianos, ...
The Lancet 352 (9142), 1725-1730, 1998
16571998
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft, B Ledergerber, C Katlama, O Kirk, P Reiss, AA Monforte, ...
The Lancet 362 (9377), 22-29, 2003
16322003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
14862006
Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study
N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk, AA Monforte, ...
Aids 17 (8), 1179-1193, 2003
13842003
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
11552008
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ...
The Lancet 384 (9939), 241-248, 2014
11052014
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill, HM Crane, ...
The lancet HIV 4 (8), e349-e356, 2017
10862017
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse …
SW Worm, C Sabin, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, ...
The Journal of infectious diseases 201 (3), 318-330, 2010
8222010
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ...
Aids 14 (5), 499-507, 2000
7592000
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
A Ammassari, R Murri, P Pezzotti, MP Trotta, L Ravasio, P De Longis, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (5), 445-449, 2001
6752001
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature
A Ammassari, MP Trotta, R Murri, F Castelli, P Narciso, P Noto, J Vecchiet, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S123-S127, 2002
6652002
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D: A: D) study
S De Wit, CA Sabin, R Weber, SW Worm, P Reiss, C Cazanave, ...
Diabetes care 31 (6), 1224-1229, 2008
6072008
Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing
E Girardi, CA Sabin, AA Monforte
JAIDS Journal of Acquired Immune Deficiency Syndromes 46, S3-S8, 2007
4542007
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
4352010
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E Fontas, F Van Leth, CA Sabin, N Friis-Møller, M Rickenbach, ...
The Journal of infectious diseases 189 (6), 1056-1074, 2004
4262004
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study
A Mocroft, R Brettle, O Kirk, A Blaxhult, JM Parkin, F Antunes, P Francioli, ...
Aids 16 (12), 1663-1671, 2002
4122002
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 …
P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ...
The Lancet 393 (10167), 143-155, 2019
3922019
The system can't perform the operation now. Try again later.
Articles 1–20